Inflammatory bowel disease in pediatric patients in Asturias, Spain, (1993-2000): Epidemiology and clinical features;Enfermedad inflamatoria intestinal en pacientes pediátricos en Asturias (1993-2000): Epidemiología y clínica

Acta Pediatrica Espanola

Volumn 62, Issue 10, 2004, Pages 466-472

  Fernandez Gonzalez N ^a   Bousono Garcia C ^a   Ramos Polo, E ^a   Crespo Hernandez M ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Crohn's disease; Epidemiology; Incidence; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CROHN DISEASE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING; SPAIN; ULCERATIVE COLITIS;

EID: 10944256197     PISSN: 00016640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. González Lara V. Enfermedad inflamatoria intestinal. Madrid: Ergon, 1995.
2. Järnerot G, Lennard-Jones J, Truelove S. Inflammatory bowel disease. Malmö, Suecia: Grafiska AB, 1992.
3. Gryboski Joyce D. Crohn's disease in children 10 years old and younger: comparison with ulcerative colitis. J Pediatr Gastroenterol Nutr 1994; 18: 174-181.
4. Russel MG, Stockbrügger R. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol 1996; 31: 417-427.
5. Trallori G, Palli D, Saieva C, Bardazzi G, Bonanomi G, D'Albasio G y cols. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol 1996; 31: 892-899.
6. Langholz E, Munkholm P, Krasilnikoff PA, Binder V. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997; 32: 139-147.
7. Björnsson S, Johannsson JH, Oddsson E. Inflammatory bowel disease in Iceland, 1980-89. Scand J Gastroenterol 1998; 33: 71-77.
8. Baldassano Robert N, Piccoli David A. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999; 28(2): 445-458.
9. Saro Gismera C, Lacort Fernández M, Argüelles Fernández G, Antón Magarzo J, García López R, Navascues CA y cols. Incidencia y prevalencia de la enfermedad inflamatoria intestinal en Gijón (Asturias). Gastroenterol Hepatol 2000; 23: 322-327.
10. Saro Gismera C, Lacort Fernández M, Arguelles Fernández G, Antón Magarzo J, Navascues CA, García López R y cols. Epidemiology of chronic inflammatory bowel disease in Gijón, Asturias. Gastroenterol Hepatol 2001; 24(5): 228-235.
11. Arin Letamendia A, Burusco Paternain MJ, Borda Celaya F, Puerto Royo A, Martínez Echevarría A. Aspectos epidemiológicos de la enfermedad inflamatoria intestinal en el área de Pamplona. Rev Esp Enfer Dig 1999; 91: 769-772.
12. Askling J, Grahnquist L, Ekbom A, Finkel Y. Incidence of paediatric Crohn's disease in Stockholm, Sweden. Lancet 1999; 354: 1.179.
13. Armitage E, Drummond H, Ghosh S, Ferguson A. Incidence of juvenile-onset Crohn's disease in Scotland. Lancet 1999; 353: 1.496-1.497.
14. Hassan K, Cowan FJ, Jenkins HR. The incidence of childhood inflammatory bowel disease in Wales. Eur J Pediatr 2000; 159: 261-263.
15. Lapidus A. The changing epidemiology of inflammatory bowel diseases. Acta Gastroenterol Belg 2001; 64(2): 155-159.
16. Sawczenko A, Sandhu BK, Logan RF, Jenkins H, Taylor CJ, Mian S y cols. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001; 357(9.262): 1.093-1.094.
17. Triantafillidis JK, Emmanouilidis A, Manousos ON, Pomonis E, Tsitsa C, Cheracakis P, Charalambos B. Ulcerative colitis in Greece: clinico epidemiological data, course and prognostic factors in 413 consecutive patients. J Clin Gastroenterol 1998; 27(3): 204-210.
18. Spanish epidemiological and economic study group on Crohn's disease. Epidemiological and clinical features of Spanish patients with Crohn's disease. Eur J Gastroenterol Hepatol 1999; 11: 1.121-1.127.
19. Nos P, Argüello L, Hoyos M, Ramírez J, Hinojosa J, Molés JR y cols. Afectación familiar en la enfermedad inflamatoria crónica intestinal. Diferencias entre grupos de pacientes con y sin historia familiar. Rev Esp Enf Digest 1996; 88: 470-474.
20. Lee JC, Lennard-Jones JE. Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology 1996; 111: 587-596.
21. Peeters M, Nevens H, Baert F, Hiele M, De Meyer AM, Vlietinck R. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996; 111: 597-603.
22. Russel MG, Pastoor CJ, Janssen KN, Van Deursen CT, Muris JW, Van Wijlick EH y cols. Familiar aggregation of inflammatory bowel disease: a population-based study in South Limburg, The Netherlands. Scand J Gastroenterol 1997; 223: 88-91.
23. Polito Jm, Rees RC, Childs B, Mendeloff AI, Harris ML, Bayless TM. Preliminary evidence for genetic anticipation in Crohn's disease. Lancet 1996; 347: 798-801.
24. Lee YT, Sunbg JJ, Poon P, Lai Kn, Li PK. Association of HLA Class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Scand J Gastroenterol 1998; 33(6): 623-627.
25. Karlinger K, Gyórke T, Makö E, Mester Á, Tarján Z. The epidemiology and pathogenesis of inflammatory bowel disease. Eur J Rad 2000; 35: 154-167.
26. Haslam N, Mayberry JF, Hawthorne AB, Newcombe RG, Holmes GK, Probert CS. Measles, month of birth and Crohn's disease. Gut 2000; 47: 801-803.
27. Morris DL, Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ. Measles vaccination and inflammatory bowel disease: a national British cohort study. Am J Gastroenterol 2000; 95: 3.507-3.511.
28. Meddings J. Barrier dysfunction and Crohn's disease. Ann NY Acad Sci 2000; 915: 333-338.
29. Russel MG, Engels LG, Muris JW, Limonard CB, Volovics A, Brummer RJ y cols. Modern life in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998; 10(39): 243-29.
30. Riordan AM, Ruxton CH, Hunter JO. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998; 52(4): 229-238.
31. Mayberry JF. Epidemiological trends in inflammatory bowel disease. J Clin Nutr Gastroenterol 1993; 8: 148-151.
32. Bustamante M, Nos P, Hoyos M, Hinojosa J, Molés JR, García-Herola A y cols. Relación entre el consuma de tabaco y la afectación colónica en la enfermedad inflamatoria crónica intestinal. Rev Esp Enferm Dig 1998; 90(12): 833-836.
33. Reif S, Lavy A, Keter D, Fich A, Eliakim R, Halak A y cols. Lack of association between smoking and Crohn's disease but usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol 2000; 95: 474-477.
34. Vergara M, Fraga X, Casellas F, Bermejo B, Malagelada JR. Influencia estacional en las exacerbaciones de la enfermedad inflamatoria intestinal. Rev Esp Enf Digest 1997; 89: 357-361.
35. Karamanolis DG, Delis KC, Papatheodoridis GV, Kalafatis E, Paspatis G, Xourgias VC. Seasonal variation in exacerbations of ulcerative colitis. Hepatogastroenterology 1997; 44(17): 1.334-1.338.
36. Meddings JB, Swain MG. Environmental stress-induced gastrointestinal pemeability is mediated by endogenous glucocoticoids in the rat. Gastroenterology 2000; 119: 1.019-1.028.
37. Russel MG, Stockbrugger RW. Epidemiological developments and insights in chronic inflammatory bowel diseases. Ned Tijdschr Geneeskd 2001; 145(34): 1.672.
38. Monferre Guardiola R, Martín Jiménez JA, Pedraza Sanz RG, Moreno Sanchez I, Soler Bahilo E, Hinojosa del Val J. Incidencia de la enfermedad inflamatoria intestinal en el area de salud 02 de Castellón (1992-1996). Rev Esp Enferm Dig 1999; 91(1): 33-39.
39. Odes HS, Fich A, Reif S, Halak A, Lavy A, Keter D y cols. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci 2001; 46(8): 1.717-1.721.